Wall Street analysts forecast that Owens & Minor (OMI) will report quarterly earnings of $0.27 per share in its upcoming release, pointing to a year-over-year decline of 25%. It is anticipated that revenues will amount to $2.73 billion, exhibiting an increase of 2.3% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
In light of this perspective, let's dive into the average estimates of certain Owens & Minor metrics that are commonly tracked and forecasted by Wall Street analysts.
According to the collective judgment of analysts, 'Net revenue- Patient Direct' should come in at $700.87 million. The estimate suggests a change of +6.1% year over year.
Analysts' assessment points toward 'Net revenue- Products & Healthcare Services' reaching $2.03 billion. The estimate points to a change of +1% from the year-ago quarter.
Based on the collective assessment of analysts, 'Operating income (loss)- Patient Direct' should arrive at $70.14 million. Compared to the current estimate, the company reported $64.79 million in the same quarter of the previous year.
Analysts forecast 'Operating income (loss)- Products & Healthcare Services' to reach $2.76 million. The estimate compares to the year-ago value of $11.47 million.
View all Key Company Metrics for Owens & Minor here>>>
Shares of Owens & Minor have demonstrated returns of -25.5% over the past month compared to the Zacks S&P 500 composite's +1.2% change. With a Zacks Rank #3 (Hold), OMI is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Owens & Minor, Inc. (OMI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
